Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30201364 | 0.80 | MEN1 (0.64) | MEN1KMT2AOPRK1 | |
| SCHEMBL30201384 | 0.78 | MEN1 (0.57) | MEN1KMT2AOPRK1 | |
| SCHEMBL6823638 | 0.76 | MEN1 (0.71) | MEN1KMT2AOPRK1L3MBTL1 | |
| SCHEMBL30201654 | 0.76 | OPRK1 (0.62) | MEN1KMT2AOPRK1 | |
| SCHEMBL30201756 | 0.76 | ROCK2 (0.61) | MEN1KMT2AOPRK1 | |
| SCHEMBL24950703 | 0.76 | OPRK1 (0.62) | MEN1KMT2AOPRK1 | |
| SCHEMBL6823539 | 0.75 | OPRK1 (0.73) | MEN1KMT2AOPRK1L3MBTL1 | |
| SCHEMBL6820560 | 0.74 | MEN1 (0.78) | MEN1KMT2AOPRK1L3MBTL1 | |
| SCHEMBL5413391 | 0.74 | ROCK2 (0.72) | MEN1KMT2AOPRK1 | |
| SCHEMBL30201262 | 0.73 | MEN1 (0.61) | MEN1KMT2AOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376818-B1 | SEROTONIN 5-HT2B INHIBITORY COMPOUNDS | ZOETIS SERVICES LLC (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2023009330-A1 | SEROTONIN 5-HT2B INHIBITORY COMPOUNDS | ZOETIS SERVICES LLC (US) | 2023-02-02 | — | — | WO | claimed |
| WO-2023009330-A1 | SEROTONIN 5-HT2B INHIBITORY COMPOUNDS | ZOETIS SERVICES LLC (US) | 2023-02-02 | — | — | WO | disclosed |